Additionally, it was reported that the overexpression of exosomal circTMEM181 secreted by tumor cells could impede the effectiveness of anti-PD-1 therapy in HCC and promote immunosuppression by upregulating the expression of CD39. Here, PDCD1 is linked to hepatocellular carcinoma.